课题基金 / 基金详情

Research on cell injury due to Carbon Monoxide and Nitric Oxide under ischemia or shock

Research on cell injury due to Carbon Monoxide and Nitric Oxide under ischemia or shock
缺血或休克时一氧化碳和一氧化氮所致细胞损伤的研究
批准号:
14370152
负责人:
YOSHIDA Ken-ichi
金额:
$9.73万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

YOSHIDA Ken-ichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Heme-oxygenase (HO)-1, generates CO, thereby protecting the cells. We have shown that a Ca^<2+>-dependent protease calpain promotes necrotic death in the cardiogenic H9c2 cells under hypoxia through α-fodrin proteolysis. The Ca^<2+>-influx, α-fodrin proteolysis and schemic death, were inhibited by CO or L-type Ca^<2+>-channel inhibitor verapamil. Ischemia also induced mitochondrial depolarization, which was inhibited by CO or verapamil. HO-1 induction reduced the Ca^<2+>-influx and cell death after ischemia. Thus, exogenous and endogenous CO protect the cardiomyogenic cells against ischemia by inhibiting Ca^<2+>-influx through L-type Ca^<2+> channel and calpain activation.After short (15, 30 min) and long (45, 60 min) time. of ischemia by coronary artery occlusion of the rats, reperfusion caused dilatation and constriction of arterioles, respectively. The vascular diameter was correlated with enhanced immunofluorescence for Akt and phosphorylated forms of serine 1177 residue 鋲NOS, and NO-bound form of guanylate cyclase (GC), as confirmed by western blotting. The constriction during reperfusion after 45 min of ischemia is related to the inhibition of Akt-mediated eNOS-Ser1177 phosphorylation, which was suppressed by a PKC inhibitor chelerythrine, a flavoprotein inhibitor DPI, or reactive oxygen species (ROS) scavengers MPG and Tiron. An endothelin receptor antagonist BQ123 alleviated the vasoconstriction by increasing NO availability but not eNOS phosphorylation. Thus, vascular patency correlated with eNOS-Ser1177 phosphorylation during ischemia-ieperfusion, and is affecled by ROS, PKC, and flavoproteins.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
Yoshida K., Kuroki H., Takeichi H., Kawai K.: "Death during surgery in Japan"The Lancet. 360(9335). 805 (2002)
Yoshida K.、Kuroki H.、Takeichi H.、Kawai K.:“日本手术期间的死亡”《柳叶刀》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Uemura K., Aki T., Yamaguchi K., Yoshida K.: "Protein kinase C-ε protects PC12 cells against methamphetamine-induced death : Possible involvement of suppression of glutamate receptor."Life Sci.. 75. 1595-1607 (2003)
Uemura K.、Aki T.、Yamaguchi K.、Yoshida K.:“蛋白激酶 C-ε 保护 PC12 细胞免受甲基苯丙胺诱导的死亡:可能涉及谷氨酸受体的抑制。”《生命科学》.. 75. 1595-1607 ( 2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Uemura K., Hoshino S., Uchida K., Tsuruta R., Maekawa T., Yoshida K.: "Hypothermia attenuates delayed cortical cell death and ROS generation following CO inhalation."Toxicol.Lett.. 145・2. 101-106 (2003)
Uemura K.、Hoshino S.、Uchida K.、Tsuruta R.、Maekawa T.、Yoshida K.:“低温可减弱吸入 CO 后延迟的皮质细胞死亡和 ROS 生成。”Toxicol.Lett.. 145・2。 106(2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
上村公一, 吉田謙一: "一酸化炭素中毒 - 基礎から臨床へ"日本医事新報. 4154. 23-28 (2003)
Koichi Uemura、Kenichi Yoshida:“一氧化碳中毒 - 从基础知识到临床实践”Nippon Iji Shinpo。4154. 23-28 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
15
    Research on rational singularities and almost Gorenstein blow-up algebras
    • 批准号:
      16K05110
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.58万
    • 财政年份:
      2016
    • 负责人:
      YOSHIDA Ken-ichi
    • 依托单位:
    Study on sudden cardiovascular death in animal model of sleep apnea syndrome
    • 批准号:
      23249038
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.87万
    • 财政年份:
      2011
    • 负责人:
      YOSHIDA Ken-ichi
    • 依托单位:
    Metabolism of inositol stereoisomers in a thermophile,Geobacillus kaustophilusHTA426
    • 批准号:
      22310130
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.06万
    • 财政年份:
      2010
    • 负责人:
      YOSHIDA Ken-ichi
    • 依托单位:
    Research of ring-invariants associated to powers of ideals
    海外基金